SIAS
IMMU

Shine Investment Advisory Services’s Immunomedics Inc IMMU Stock Holding History

Shine Investment Advisory Services’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$10K Sell
122
-298
-71% -$15.1K ﹤0.01% 556
2020
Q2 		$15K Buy
+420
New +$12.3K 0.01% 497

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Shine Investment Advisory Services's IMMU Position: Q3 2020 in Review

Shine Investment Advisory Services reduced its Immunomedics Inc (IMMU) stake by 71% in Q3 2020, selling an estimated $15.1K and leaving 122 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #556.

Shine Investment Advisory Services first reported a position in IMMU in Q2 2020 and has held it in 2 quarters since. The position peaked at $15K in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Shine Investment Advisory Services held 122 shares of Immunomedics Inc worth $10K as of Q3 2020.
  • Shine Investment Advisory Services sold 298 Immunomedics Inc shares in Q3 2020, an estimated $15.1K.
  • Immunomedics Inc made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #556 holding.
  • Shine Investment Advisory Services first reported a position in Immunomedics Inc in Q2 2020 and has held it in 2 quarters since.
  • Shine Investment Advisory Services's Immunomedics Inc position peaked at $15K in Q2 2020.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.